Sato Junya, Tanaka Rei
Department of Pharmacy, International University of Health and Welfare Hospital, 537-3 Iguchi, Nasushiobara City, Tochigi Prefecture, 329-2763, Japan.
School of Pharmacy, International University of Health and Welfare, Ohtawara City, Kitakanemaru, Tochigi Prefecture, 2600-1324-8501, Japan.
Support Care Cancer. 2022 Jun;30(6):4889-4896. doi: 10.1007/s00520-022-06903-z. Epub 2022 Feb 15.
For the treatment of delirium, antipsychotics such as haloperidol are used as standard treatments. However, haloperidol has a little sedative effect and may not be sufficiently effective in controlling overactive delirium. Hydroxyzine, an antihistamine, may be used in combination with haloperidol to supplement its sedative effect. The aim of this study was to investigate the effect of haloperidol alone or in combination with hydroxyzine on the improvement of overactive delirium retrospectively.
Delirium was assessed from medical records using the Intensive Care Delirium Screening Checklist (ICDSC). The number of patients and days with an ICDSC score of < 4, indicating an absence of delirium after haloperidol alone or haloperidol and hydroxyzine was surveyed for 6 days.
A total of 157 patients were diagnosed with delirium from April 2019 to July 2021, of which 18 patients received haloperidol alone, and 21 patients received the combination of haloperidol and hydroxyzine for overactive delirium. The number of patients with a mean ICDSC score of < 4 on days 1-6 was two patients (11%) in the haloperidol groups and two patients (10%) in the combination of haloperidol and hydroxyzine group (P = 0.999). The days within < 4 of the ICDSC score on days 1-6 were 0.8 (1.3) and 0.8 (1.5), respectively (P = 0.848).
Haloperidol alone and haloperidol plus hydroxyzine are both effective in the treatment of overactive delirium. However, the concomitant use of hydroxyzine with haloperidol may not improve the efficacy of treatment of overactive delirium compared to haloperidol alone.
对于谵妄的治疗,氟哌啶醇等抗精神病药物被用作标准治疗方法。然而,氟哌啶醇的镇静作用较弱,在控制激越性谵妄方面可能效果不够显著。羟嗪作为一种抗组胺药,可与氟哌啶醇联合使用以补充其镇静作用。本研究的目的是回顾性调查单独使用氟哌啶醇或与羟嗪联合使用对改善激越性谵妄的效果。
使用重症监护谵妄筛查清单(ICDSC)从病历中评估谵妄情况。对单独使用氟哌啶醇或氟哌啶醇与羟嗪联合使用6天后ICDSC评分<4(表明无谵妄)的患者数量和天数进行调查。
2019年4月至2021年7月期间,共有157例患者被诊断为谵妄,其中18例患者单独接受氟哌啶醇治疗,21例患者接受氟哌啶醇与羟嗪联合治疗以控制激越性谵妄。在第1 - 6天,氟哌啶醇组平均ICDSC评分<4的患者有2例(11%),氟哌啶醇与羟嗪联合治疗组有2例(10%)(P = 0.999)。在第1 - 6天ICDSC评分<4的天数分别为0.8(1.3)天和0.8(1.5)天(P = 0.848)。
单独使用氟哌啶醇和氟哌啶醇加羟嗪在治疗激越性谵妄方面均有效。然而,与单独使用氟哌啶醇相比,羟嗪与氟哌啶醇联合使用可能无法提高激越性谵妄的治疗效果。